186 related articles for article (PubMed ID: 20864577)
1. Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.
Stadtmauer EA; Vogl DT; Luning Prak E; Boyer J; Aqui NA; Rapoport AP; McDonald KR; Hou X; Murphy H; Bhagat R; Mangan PA; Chew A; Veloso EA; Levine BL; Vonderheide RH; Jawad AF; June CH; Sullivan KE
Blood; 2011 Jan; 117(1):63-71. PubMed ID: 20864577
[TBL] [Abstract][Full Text] [Related]
2. Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.
Rapoport AP; Aqui NA; Stadtmauer EA; Vogl DT; Fang HB; Cai L; Janofsky S; Chew A; Storek J; Akpek G; Badros A; Yanovich S; Tan MT; Veloso E; Pasetti MF; Cross A; Philip S; Murphy H; Bhagat R; Zheng Z; Milliron T; Cotte J; Cannon A; Levine BL; Vonderheide RH; June CH
Blood; 2011 Jan; 117(3):788-97. PubMed ID: 21030558
[TBL] [Abstract][Full Text] [Related]
3. Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.
Rapoport AP; Aqui NA; Stadtmauer EA; Vogl DT; Xu YY; Kalos M; Cai L; Fang HB; Weiss BM; Badros A; Yanovich S; Akpek G; Tsao P; Cross A; Mann D; Philip S; Kerr N; Brennan A; Zheng Z; Ruehle K; Milliron T; Strome SE; Salazar AM; Levine BL; June CH
Clin Cancer Res; 2014 Mar; 20(5):1355-65. PubMed ID: 24520093
[TBL] [Abstract][Full Text] [Related]
4. A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.
Qazilbash MH; Saini NY; Cha SC; Wang Z; Stadtmauer EA; Baladandayuthapani V; Lin H; Tross B; Honhar M; Rao SS; Kim K; Popescu M; Szymura S; Zhang T; Anderson A; Bashir Q; Shpall EJ; Orlowski RZ; Levine BL; Kerr N; Garfall A; Cohen A; Vogl DT; Dengel K; June CH; Champlin R; Kwak LW
Blood; 2022 Mar; 139(9):1289-1301. PubMed ID: 34521108
[TBL] [Abstract][Full Text] [Related]
5. Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.
Rapoport AP; Stadtmauer EA; Aqui N; Vogl D; Chew A; Fang HB; Janofsky S; Yager K; Veloso E; Zheng Z; Milliron T; Westphal S; Cotte J; Huynh H; Cannon A; Yanovich S; Akpek G; Tan M; Virts K; Ruehle K; Harris C; Philip S; Vonderheide RH; Levine BL; June CH
Clin Cancer Res; 2009 Jul; 15(13):4499-507. PubMed ID: 19509133
[TBL] [Abstract][Full Text] [Related]
6. Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.
Rapoport AP; Stadtmauer EA; Aqui N; Badros A; Cotte J; Chrisley L; Veloso E; Zheng Z; Westphal S; Mair R; Chi N; Ratterree B; Pochran MF; Natt S; Hinkle J; Sickles C; Sohal A; Ruehle K; Lynch C; Zhang L; Porter DL; Luger S; Guo C; Fang HB; Blackwelder W; Hankey K; Mann D; Edelman R; Frasch C; Levine BL; Cross A; June CH
Nat Med; 2005 Nov; 11(11):1230-7. PubMed ID: 16227990
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.
Rosenblatt J; Avivi I; Vasir B; Uhl L; Munshi NC; Katz T; Dey BR; Somaiya P; Mills H; Campigotto F; Weller E; Joyce R; Levine JD; Tzachanis D; Richardson P; Laubach J; Raje N; Boussiotis V; Yuan YE; Bisharat L; Held V; Rowe J; Anderson K; Kufe D; Avigan D
Clin Cancer Res; 2013 Jul; 19(13):3640-8. PubMed ID: 23685836
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma.
Grupp SA; Prak EL; Boyer J; McDonald KR; Shusterman S; Thompson E; Callahan C; Jawad AF; Levine BL; June CH; Sullivan KE
Clin Cancer Res; 2012 Dec; 18(24):6732-41. PubMed ID: 23092876
[TBL] [Abstract][Full Text] [Related]
9. Autologous Lymphocyte Infusion Supports Tumor Antigen Vaccine-Induced Immunity in Autologous Stem Cell Transplant for Multiple Myeloma.
Cohen AD; Lendvai N; Nataraj S; Imai N; Jungbluth AA; Tsakos I; Rahman A; Mei AH; Singh H; Zarychta K; Kim-Schulze S; Park A; Venhaus R; Alpaugh K; Gnjatic S; Cho HJ
Cancer Immunol Res; 2019 Apr; 7(4):658-669. PubMed ID: 30745365
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant.
Villa D; Gubbay J; Sutherland DR; Laister R; McGeer A; Cooper C; Fortuno ES; Xu W; Shi L; Kukreti V; Crump M; Kuruvilla J
Leuk Lymphoma; 2013 Jul; 54(7):1387-95. PubMed ID: 23240909
[TBL] [Abstract][Full Text] [Related]
11. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study.
Reichardt VL; Okada CY; Liso A; Benike CJ; Stockerl-Goldstein KE; Engleman EG; Blume KG; Levy R
Blood; 1999 Apr; 93(7):2411-9. PubMed ID: 10090953
[TBL] [Abstract][Full Text] [Related]
12. Impact of ageing and a synbiotic on the immune response to seasonal influenza vaccination; a randomised controlled trial.
Enani S; Przemska-Kosicka A; Childs CE; Maidens C; Dong H; Conterno L; Tuohy K; Todd S; Gosney M; Yaqoob P
Clin Nutr; 2018 Apr; 37(2):443-451. PubMed ID: 28215759
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific T-cell immunity in multiple myeloma patients is restored following high-dose therapy: implications for timing of vaccination.
Svane IM; Nikolajsen K; Johnsen HE
Scand J Immunol; 2007 Oct; 66(4):465-75. PubMed ID: 17850592
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
Moreau P; Attal M; Hulin C; Arnulf B; Belhadj K; Benboubker L; Béné MC; Broijl A; Caillon H; Caillot D; Corre J; Delforge M; Dejoie T; Doyen C; Facon T; Sonntag C; Fontan J; Garderet L; Jie KS; Karlin L; Kuhnowski F; Lambert J; Leleu X; Lenain P; Macro M; Mathiot C; Orsini-Piocelle F; Perrot A; Stoppa AM; van de Donk NW; Wuilleme S; Zweegman S; Kolb B; Touzeau C; Roussel M; Tiab M; Marolleau JP; Meuleman N; Vekemans MC; Westerman M; Klein SK; Levin MD; Fermand JP; Escoffre-Barbe M; Eveillard JR; Garidi R; Ahmadi T; Zhuang S; Chiu C; Pei L; de Boer C; Smith E; Deraedt W; Kampfenkel T; Schecter J; Vermeulen J; Avet-Loiseau H; Sonneveld P
Lancet; 2019 Jul; 394(10192):29-38. PubMed ID: 31171419
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
16. Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial.
Abdelkefi A; Ladeb S; Torjman L; Othman TB; Lakhal A; Romdhane NB; Omri HE; Elloumi M; Belaaj H; Jeddi R; Aissaouï L; Ksouri H; Hassen AB; Msadek F; Saad A; Hsaïri M; Boukef K; Amouri A; Louzir H; Dellagi K; Abdeladhim AB;
Blood; 2008 Feb; 111(4):1805-10. PubMed ID: 17875806
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.
Rosendahl Huber SK; Hendriks M; Jacobi RHJ; van de Kassteele J; Mandersloot-Oskam JC; van Boxtel RAJ; Wensing AMJ; Rots NY; Luytjes W; van Beek J
Front Immunol; 2018; 9():3103. PubMed ID: 30761157
[TBL] [Abstract][Full Text] [Related]
18. Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.
de Lavallade H; Garland P; Sekine T; Hoschler K; Marin D; Stringaris K; Loucaides E; Howe K; Szydlo R; Kanfer E; Macdonald D; Kelleher P; Cooper N; Khoder A; Gabriel IH; Milojkovic D; Pavlu J; Goldman JM; Apperley JF; Rezvani K
Haematologica; 2011 Feb; 96(2):307-14. PubMed ID: 20971824
[TBL] [Abstract][Full Text] [Related]
19. Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients.
Orcurto A; Pascual M; Hoschler K; Aubert V; Meylan P; Manuel O
Transplantation; 2012 Sep; 94(6):630-6. PubMed ID: 22895612
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial.
Branagan AR; Duffy E; Albrecht RA; Cooper DL; Seropian S; Parker TL; Gan G; Li F; Zelterman D; Boddupalli CS; Zhang L; Verma R; Ferencz TM; Dhodapkar MV
Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):296-304.e2. PubMed ID: 28343904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
